Bayer Schering GmbHBayer Aktiengesellschaft • November 30th, 2006 • Pharmaceutical preparations
A Domination and Profit and Loss Transfer Agreement (hereinafter, the “DPLTA”) pursuant to § 291 para. 1 German Stock Corporations Act [Aktiengesetz, “AktG”] was entered into on 31 July 2006 between Bayer Schering GmbH (previously Dritte BV GmbH), Leverkusen, a wholly owned subsidiary of Bayer AG, Leverkusen (hereinafter, “Bayer Schering”) as the dominating company and Schering Aktiengesellschaft, Berlin, (hereinafter, “Schering”) as the controlled company. The shareholders meeting of Bayer Schering approved the DPLTA on 22 August 2006. The extraordinary general meeting of Schering approved the DPLTA on 13 September 2006. The DPLTA took effect upon registration in the commercial register at the Local Court [Amtsgericht] Charlottenburg, Berlin on 27 October 2006. The announcement of the registration pursuant to § 10 German Commercial Code [Handelsgesetzbuch, “HGB”] was made on 9 November 2006 in the Federal Gazette [Bundesanzeiger] and on 24 November 2006 in ‘Der Tagesspiegel’ newspaper
